 |
 |
|
|
RESÚMENES ENERO 2005 |
Other Neuropsychiatric Disorders & General Information
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Topiramate
in migraine prophylaxis: a randomised double-blind versus placebo study
D. Mei,
A. Capuano, C. Vollono, M. Evangelista, D. Ferraro,
P. Tonali and G. Di Trapani
Neurological Sciences 2004; Volume 25, Number
5: 245 - 250
Psychiatric Effects of Ephedra Use: An Analysis of Food and Drug Administration Reports of Adverse Events
Margaret Maglione, Karen Miotto, Martin Iguchi, Lara Jungvig, Sally C.
Morton, and Paul G. Shekelle
Am J Psychiatry 162:189-191, January 2005
The value of cranial computed tomography in old age psychiatry: a review of the results of 178 consecutive scans
Sian Fielding, Specialist Registrar
Psychiatric Bulletin (2005) 29: 21-23
Markku Anttila,
Eero A. Sotaniemi, Olavi Pelkonen and Arja Rautio
Clinical Pharmacology & Therapeutics. Volume 77,
Issue 1, January 2005, Pages 54-62
Multi-functional drugs for various CNS
targets in the treatment of neurodegenerative disorders
Moussa B.H. Youdim
and Jerry J. Buccafusco
Trends in Pharmacological Sciences. Volume 26, Issue
1, January 2005, Pages 27-35
G Terence Wilson,
and Roz Shafran
The Lancet. Volume 365, Issue 9453, 1 January 2005,
Pages 79-81
Claudio Napoli and
Wulf Palinski
Neurobiology of Aging. Volume 26, Issue 3, March 2005,
Pages 293-302
Minimally Effective Doses of Conventional Antipsychotic Medications Used
to Treat Aggression, Self-Injurious and Destructive Behaviors in Mentally
Retarded Adults.
Janowsky, David S.; Barnhill, L. Jarrett;
Shetty, Mahesh; Davis, John M.
Journal of Clinical Psychopharmacology. 25(1):19-25,
February 2005
Effects of the Androgen Antagonist Flutamide and the Serotonin Reuptake
Inhibitor Citalopram in Bulimia Nervosa: A Placebo-Controlled Pilot Study.
Sundblad, Charlotta; Landen, Mikael;
Eriksson, Tomas; Bergman, Lars; Eriksson, Elias
Journal
of Clinical Psychopharmacology. 25(1):85-88, February 2005
Jerónimo Saiz-Ruiz,
Carlos Blanco, Angela Ibáñez, Xavier Masramon, Margarita M. Gómez, María
Madrigal, and Teresa Díez
J Clin Psychiatry 2005;66:28-33
Assessing the Utility of Atypical Antipsychotic Medication
in Adults With Mild Mental Retardation and Comorbid Psychiatric Disorders
Karen J. Shedlack,
John Hennen, Christine Magee, and Daniel M. Cheron
J Clin Psychiatry 2005;66:52-62
Complexity of Medication Use in the Veterans Affairs Healthcare System:
Part I: Outpatient Use in Relation to Age and Number of Prescribers.
PRESKORN, SHELDON H.; SILKEY, BERYL; SHAH,
ROZINA; NEFF, MELISSA; JONES, TERESA L; CHOI, JOE; GOLBECK, AMANDA L
Journal of Psychiatric Practice. 11(1):5-15, January
2005
Efficacy of Duloxetine, a Potent and Balanced Serotonergic and Noradrenergic Reuptake Inhibitor, in Inflammatory and Acute Pain Models in Rodents
Carrie K. Jones, Steven C. Peters, and Harlan E. Shannon
Can J Psychiatry 2004;49:736-742
Screening for Dementia: Recommendations and Rationale: United States Preventive Services Task Force
United States
Preventive Services Task Force
The Internet Journal of Mental Health. 2004. Volume 2
Number 1
Relationships
between serotonin transporter promoter polymorphism, platelet serotonin
transporter binding and clinical phenotype in suicidal and non-suicidal
adolescent inpatients
G. Zalsman, G.
M. Anderson, M. Peskin, A. Frisch, R. A. King,
M. Vekslerchik, E. Sommerfeld, E. Michaelovsky, L. Sher,
A. Weizman and A. Apter
Journal of Neural Transmission 2005;Volume 112, Number
2: 309 - 315
Testosterone
administration attenuates regional brain hypometabolism in women with anorexia
nervosa
Karen K. Miller,
Thilo Deckersbach, Scott L. Rauch, Alan J. Fischman, Kelly A. Grieco, David B.
Herzog and Anne Klibanski
Psychiatry Research: Neuroimaging. Volume 132, Issue
3, 30 December 2004, Pages 197-207
Adult Attention
Deficit Hyperactivity Disorder Identified by Neuropsychological Testing
NIELS DIGE and GUSTAV WIK
International Journal of Neuroscience 2005;Volume 115, Number
2:169 - 183
D Gunnell, P K E Magnusson, F Rasmussen
Sheree
J. Gibb , Annette L. Beautrais, David M. Fergusson
Australian and New Zealand Journal of Psychiatry.
Volume 39 Issue 1-2 Page 95 - January 2005
Julia
Godress , Salih Ozgul, Cathy Owen, Leanne Foley-Evans
Australian and New Zealand Journal of Psychiatry.
Volume 39 Issue 1-2 Page 88 - January 2005
Evaluation of
cholinergic markers in Alzheimer's disease and in a model of cholinergic
deficit
Francisco Javier
Gil-Bea, Mónica García-Alloza, Jon Domínguez, Beatriz Marcos and María Javier
Ramírez
Neuroscience Letters. Volume 375, Issue 1, 25 February
2005, Pages 37-41
Prevalence of attention deficit–/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates
M. Rösler,
W. Retz, P. Retz-Junginger, G. Hengesch, M. Schneider,
T. Supprian, P. Schwitzgebel, K. Pinhard, N. Dovi–Akue,
P. Wender and J. Thome
European Archives of Psychiatry and Clinical
Neuroscience 2005; Volume 254, Number 6: 365 - 371
Daniel
J. Brotman, Esteban Walker, Michael S. Lauer, Ralph G. O’Brien
Arch Intern Med. 2005;165:138-145
Drugs with
anticholinergic properties and cognitive performance in the elderly: results
from the PAQUID Study
Nathalie
Lechevallier-Michel, Mathieu Molimard, Jean-François Dartigues, Colette
Fabrigoule & Annie Fourrier-Réglat
British Journal of Clinical Pharmacology Volume
59 Issue 2 Page 143 - February 2005
Fernando
Rico-Villademoros, Javier Hidalgo, Inmaculada Dominguez, Juan Miguel
García-Leiva and Elena Pita Calandre
Mental Health Service Delivery and Suicide Risk: The Role of Individual Patient and Facility Factors
Rani A. Desai, David J. Dausey, and Robert A. Rosenheck
Am J Psychiatry 162:311-318, February 2005
Placebo-Controlled Study of Pimozide Augmentation of Fluoxetine in Body Dysmorphic Disorder
Katharine A. Phillips